Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President, Interim CFO, Director
-
Stock Symbol
-
ZNTL on Nasdaq
Cam Gallagher - trading volume in the past year for Zentalis Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
634K |
$7.59M |
$11.98 |
May 31, 2024 |
Direct |
|
|
Stock Option (Right to Buy) |
193K |
|
|
Feb 1, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.